Celexa, Lexapro Buyers Want Class Cert. In Marketing MDL
Two mothers accusing Forest Laboratories Inc. of misleading consumers about the efficacy of its antidepressants Celexa and Lexapro for children on Thursday asked for class certification, telling a Massachusetts federal court...To view the full article, register now.
Already a subscriber? Click here to view full article